Ancillary tests in the diagnosis of liver and pancreatic neoplasms (Q91198288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

title

Ancillary tests in the diagnosis of liver and pancreatic neoplasms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Barbara A Centeno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

Martha B Pitman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

publication date

1 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

volume

126 Suppl 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

672-690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas

20 April 2020

cites work

1 reference

7 January 2021

Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections

1 reference

7 January 2021

Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.

1 reference

7 January 2021

Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.

1 reference

7 January 2021

Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens

1 reference

7 January 2021

Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma

1 reference

7 January 2021

Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology

1 reference

7 January 2021

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

1 reference

7 January 2021

Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.

1 reference

7 January 2021

Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology

1 reference

7 January 2021

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes

1 reference

7 January 2021

Genotype phenotype classification of hepatocellular adenoma

1 reference

7 January 2021

Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma

1 reference

7 January 2021

Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas

1 reference

7 January 2021

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

1 reference

7 January 2021

Anatomic pathology of hepatocellular carcinoma: histopathology using classic and new diagnostic tools

1 reference

7 January 2021

Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.

1 reference

7 January 2021

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

7 January 2021

Molecular genetics of pancreatic intraepithelial neoplasia

1 reference

7 January 2021

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray

1 reference

7 January 2021

Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct

1 reference

7 January 2021

K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis

1 reference

7 January 2021

Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas

1 reference

7 January 2021

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas

1 reference

7 January 2021

Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

1 reference

7 January 2021

Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity

1 reference

7 January 2021

Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis

1 reference

7 January 2021

Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases

1 reference

7 January 2021

Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers

1 reference

7 January 2021

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations

1 reference

7 January 2021

Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas

1 reference

7 January 2021

Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma.

1 reference

7 January 2021

Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate

1 reference

7 January 2021

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

1 reference

7 January 2021

A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

1 reference

7 January 2021

The role of cytopathology and cyst fluid analysis in the preoperative diagnosis and management of pancreatic cysts >3 cm.

1 reference

7 January 2021

Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts

1 reference

7 January 2021

Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms

1 reference

7 January 2021

Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology

1 reference

7 January 2021

Pancreatic cyst fluid triage: a critical component of the preoperative evaluation of pancreatic cysts

1 reference

7 January 2021

Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms

1 reference

7 January 2021

Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.

1 reference

7 January 2021

Cyst Fluid Carcinoembryonic Antigen Is an Accurate Diagnostic Marker of Pancreatic Mucinous Cysts

1 reference

7 January 2021

Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study

1 reference

7 January 2021

Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis

1 reference

7 January 2021

Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis.

1 reference

7 January 2021

Nodular fasciitis clinically presenting as a sarcoma

1 reference

7 January 2021

Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms

1 reference

7 January 2021

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development

1 reference

7 January 2021

High‐grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than “positive” cytology

1 reference

7 January 2021

Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis.

1 reference

7 January 2021

Standardized terminology and nomenclature for pancreatobiliary cytology: the Papanicolaou Society of Cytopathology guidelines.

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNCY.22009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30156777 AND SRC:MED&resulttype=core&format=json

20 April 2020

1 reference